Excedrin by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.
Reye’s syndrome:Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Allergy alert:Acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
Allergy alert:Aspirin may cause a severe allergic reaction which may include:
Liver warning:This product contains acetaminophen. Severe liver damage may occur if you take
Stomach bleeding warning:This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
Caffeine warning:The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heart beat.
These could be signs of a serious condition.
NDC: 0067-8203-04
EXCEDRIN
EXTRA STRENGTH
Acetaminophen, Aspirin (NSAID) and Caffeine
Pain Reliever/Pain Reliever Aid
300 CAPLETS
TAMPER-EVIDENT BOTTLE
DO NOT USE IF PRINTED INNER SAFETY SEAL
UNDER CAP IS BROKEN OR MISSING
Distributed by: GSK Consumer Healthcare
Warren, NJ 07059
©2020 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.
B-0630-763-17 – Front Carton
EXCEDRIN
EXTRA STRENGTH PAIN RELIEVER
acetaminophen, aspirin (nsaid), and caffeine tablet, film coated |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Labeler - Haleon US Holdings LLC (079944263) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EXCEDRIN 98594008 not registered Live/Pending |
Haleon CH SARL 2024-06-10 |
EXCEDRIN 97425413 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-05-24 |
EXCEDRIN 97210682 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
EXCEDRIN 97210676 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
EXCEDRIN 86434099 4978864 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2014-10-24 |
EXCEDRIN 85243455 3985911 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2011-02-16 |
EXCEDRIN 74504161 1892912 Dead/Cancelled |
Bristol-Myers Squibb Company 1994-03-23 |
EXCEDRIN 73661685 1472811 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1987-05-18 |
EXCEDRIN 72080162 0696323 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1959-08-25 |